Chin-King Looi

1.3k total citations · 1 hit paper
11 papers, 888 citations indexed

About

Chin-King Looi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chin-King Looi has authored 11 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chin-King Looi's work include Pancreatic and Hepatic Oncology Research (2 papers), Viral-associated cancers and disorders (2 papers) and CAR-T cell therapy research (2 papers). Chin-King Looi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Viral-associated cancers and disorders (2 papers) and CAR-T cell therapy research (2 papers). Chin-King Looi collaborates with scholars based in Malaysia, China and France. Chin-King Looi's co-authors include Chee‐Onn Leong, Shew Fung Wong, Ling‐Wei Hii, Wei‐Meng Lim, Maxine Swee‐Li Yee, Yih-Yih Kok, Chiew-Yen Wong, Chun‐Wai Mai, Felicia Fei‐Lei Chung and Rozita Rosli and has published in prestigious journals such as Frontiers in Immunology, Cancer Letters and Cancers.

In The Last Decade

Chin-King Looi

10 papers receiving 867 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Microplastics and Nanoplastics on Human Health

2021 628 citations Maxine Swee‐Li Yee, Ling‐Wei Hii et al. Nanomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chin-King Looi Malaysia	8	547	324	163	137	135	11	888
Dandan Sheng China	21	447 0.8×	206 0.6×	321 2.0×	164 1.2×	208 1.5×	45	1.6k
Yiqi Wu China	20	397 0.7×	179 0.6×	110 0.7×	76 0.6×	57 0.4×	50	1.1k
Yunfei Ding China	11	562 1.0×	250 0.8×	183 1.1×	183 1.3×	30 0.2×	21	919
Constanza Cortés Spain	17	564 1.0×	258 0.8×	261 1.6×	355 2.6×	58 0.4×	19	1.1k
Sharifah Emilia Tuan Sharif Malaysia	8	373 0.7×	243 0.8×	81 0.5×	58 0.4×	44 0.3×	37	589
Jin Soo Choi South Korea	18	632 1.2×	270 0.8×	121 0.7×	277 2.0×	37 0.3×	48	1.2k
Dominique Goudounèche France	15	502 0.9×	402 1.2×	85 0.5×	83 0.6×	29 0.2×	31	1.0k
I‐Jen Chiu Taiwan	12	345 0.6×	181 0.6×	116 0.7×	146 1.1×	30 0.2×	19	699
Qiuqiang Chen China	14	1.4k 2.5×	1.1k 3.5×	170 1.0×	213 1.6×	97 0.7×	25	1.9k
Xue Wen China	16	268 0.5×	72 0.2×	111 0.7×	143 1.0×	99 0.7×	33	845

Countries citing papers authored by Chin-King Looi

Since Specialization

Citations

This map shows the geographic impact of Chin-King Looi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin-King Looi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin-King Looi more than expected).

Fields of papers citing papers by Chin-King Looi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin-King Looi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin-King Looi. The network helps show where Chin-King Looi may publish in the future.

Co-authorship network of co-authors of Chin-King Looi

This figure shows the co-authorship network connecting the top 25 collaborators of Chin-King Looi. A scholar is included among the top collaborators of Chin-King Looi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin-King Looi. Chin-King Looi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Lee, Eleanor S., Chin-King Looi, Yik-Ling Chew, et al.. (2025). Targeting radiotherapy-induced inflammation in cancer metastasis: insights into immune modulation, therapeutic opportunities and radiogenomics. Frontiers in Oncology. 15. 1682522–1682522.

2.

Looi, Chin-King, E. M. van der Loo, Yik-Ling Chew, et al.. (2024). Revolutionizing the treatment for nasopharyngeal cancer: the impact, challenges and strategies of stem cell and genetically engineered cell therapies. Frontiers in Immunology. 15. 1484535–1484535. 2 indexed citations

3.

Looi, Chin-King, Felicia Fei‐Lei Chung, Alan Soo Beng Khoo, et al.. (2023). Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer. Cell Biology and Toxicology. 39(6). 2501–2526. 8 indexed citations

4.

Looi, Chin-King, Ling‐Wei Hii, Felicia Fei‐Lei Chung, et al.. (2022). Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer. Cancers. 14(15). 3709–3709. 6 indexed citations

5.

Liew, Kitson, Ling‐Wei Hii, Wei‐Meng Lim, et al.. (2021). Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma. Cancer Letters. 504. 81–90. 12 indexed citations

6.

Looi, Chin-King, Ling‐Wei Hii, Felicia Fei‐Lei Chung, et al.. (2021). Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer. Cancers. 13(8). 1786–1786. 20 indexed citations

7.

Chung, Ivy, Azad Hassan Abdul Razack, Felicia Fei‐Lei Chung, et al.. (2021). Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells. Journal of Cellular and Molecular Medicine. 25(17). 8187–8200. 8 indexed citations

8.

Yee, Maxine Swee‐Li, Ling‐Wei Hii, Chin-King Looi, et al.. (2021). Impact of Microplastics and Nanoplastics on Human Health. Nanomaterials. 11(2). 496–496. 628 indexed citations breakdown →

9.

Looi, Chin-King, Ling‐Wei Hii, Siew Ching Ngai, Chee‐Onn Leong, & Chun‐Wai Mai. (2020). The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?. Biomedicines. 8(9). 334–334. 54 indexed citations

10.

Looi, Chin-King, Felicia Fei‐Lei Chung, Chee‐Onn Leong, et al.. (2019). Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. Journal of Experimental & Clinical Cancer Research. 38(1). 162–162. 142 indexed citations

11.

Padmavathy, Krishnaraj, et al.. (2019). Phenothiazine and amide-ornamented dihydropyridinesviaa molecular hybridization approach: design, synthesis, biological evaluation and molecular docking studies. New Journal of Chemistry. 43(43). 17046–17057. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact